{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:13:45Z","timestamp":1778022825466,"version":"3.51.4"},"reference-count":10,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":483,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Apheresis"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1002\/jca.21324","type":"journal-article","created":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T12:49:27Z","timestamp":1399380567000},"page":"43-45","source":"Crossref","is-referenced-by-count":19,"title":["Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase"],"prefix":"10.1002","volume":"30","author":[{"given":"Masatake","family":"Kobayashi","sequence":"first","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University; Hachioji Medical Center; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Nanri","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Medical University; Hachioji Medical Center; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Medical University; Hachioji Medical Center; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Ishiko","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Medical University; Hachioji Medical Center; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Medical University; Hachioji Medical Center; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Medical University; Hachioji Medical Center; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Sugisaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Medical University; Hachioji Medical Center; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Medical University; Hachioji Medical Center; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,5,6]]},"reference":[{"key":"10.1002\/jca.21324-BIB0001|jca21324-cit-0001","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1590\/S0004-282X2012001000010","article-title":"The expanded spectrum of neuromyelitis optica: evidences for a new definition","volume":"70","author":"Lana-Peixoto","year":"2012","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1002\/jca.21324-BIB0002|jca21324-cit-0002","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1590\/S0004-282X2012000100012","article-title":"Treatment of neuromyelitis optica: an evidence based review","volume":"70","author":"Sato","year":"2012","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1002\/jca.21324-BIB0003|jca21324-cit-0003","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jca.21219","article-title":"Neurologic indications for therapeutic plasma exchange: 2011 update","volume":"27","author":"Gwathmey","year":"2012","journal-title":"J Clin Apher"},{"key":"10.1002\/jca.21324-BIB0004|jca21324-cit-0004","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1742-2094-9-80","article-title":"Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis","volume":"9","author":"Koziolek","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1002\/jca.21324-BIB0005|jca21324-cit-0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.atherosclerosissup.2012.10.025","article-title":"Immunoadsorption in steroid-refractory multiple sclerosis: clinical experience in 60 patients","volume":"14","author":"Heigl","year":"2013","journal-title":"Atheroscler Suppl"},{"key":"10.1002\/jca.21324-BIB0006|jca21324-cit-0006","first-page":"787630","article-title":"Plasma exchange in severe attacks of neuromyelitis optica","volume":"2012","author":"Bonnan","year":"2012","journal-title":"Mult Scler Int"},{"key":"10.1002\/jca.21324-BIB0007|jca21324-cit-0007","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jocn.2010.07.141","article-title":"Therapeutic efficacy of double filtration plasmapheresis in patients with anti-aquaporin-4 antibody-positive multiple sclerosis","volume":"18","author":"Munemotoa","year":"2011","journal-title":"J Clin Neurosci"},{"key":"10.1002\/jca.21324-BIB0008|jca21324-cit-0008","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3988\/jcn.2013.9.1.36","article-title":"Clinical efficacy of PP in patients with NMO and effects on circulating anti-AQP4 antibody levels","volume":"9","author":"Kim","year":"2013","journal-title":"J Clin Neurol"},{"key":"10.1002\/jca.21324-BIB0009|jca21324-cit-0009","first-page":"111","article-title":"A case of subacute myelitis with anti-aquaporin 4 antibody after thymectomy for myasthenia gravis: review of autoimmune disease after thymectomy","volume":"50","author":"Kohsaka","year":"2010","journal-title":"Clin Neurol"},{"key":"10.1002\/jca.21324-BIB0010|jca21324-cit-0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1212\/WNL.58.1.143","article-title":"Plasma exchange for severe attacks of CNS demyelination: predictors of response","volume":"58","author":"Keegan","year":"2002","journal-title":"Neurology"}],"container-title":["Journal of Clinical Apheresis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjca.21324","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jca.21324\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T17:29:50Z","timestamp":1625506190000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jca.21324"}},"subtitle":["IA Therapy for NMOSD Long After the Acute Phase"],"short-title":[],"issued":{"date-parts":[[2014,5,6]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"URL":"https:\/\/doi.org\/10.1002\/jca.21324","relation":{},"ISSN":["0733-2459"],"issn-type":[{"value":"0733-2459","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5,6]]}}}